[138 Pages Report] Vascular access devices include central vascular access devices, peripheral vascular access devices, and accessories. The global vascular access device market is projected to grow from USD 3.87 Billion in 2017 to reach to USD 5.45 Billion by 2022 at a CAGR of 7.1%. Base year considered for the report is 2016.

The key factors driving the growth of this market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients.

Objectives of the Study

To define, describe, and forecast the vascular access devices market by type, application, end user, and region

To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders

To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

To profile the key players and analyze their market shares and core competencies

To track and analyze competitive developments such as product launches, approval, agreements, collaborations, and acquisitions in the global market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of other dependent submarkets. Various secondary sources such as associations World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Association of Percutaneous Cardiovascular Interventions (EAPCI) directories, Society for Cardiac Angiography and Interventions (SCAI), industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study ofthis market. Primary sources such as experts from both supply and demand sides have been interviewed to obtainand validateinformation as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global vascular access device market are Becton, Dickinson and Company (U.S.), C. R. Bard, Inc. (U.S.), Smiths Medical, Inc. (U.K.), Teleflex Incorporated (U.S.), B.Braun Melsungen AG (Germany), NIPRO Medical Corporation (Japan), Edwards Lifesciences Corporation (U.S.), Terumo Corporation (Japan), Vygon Ltd. (U.K.), Ameco Medical (Egypt), AngioDynamics (U.S.), Romsons Scientific & Surgical Pvt. Ltd. (India), and PRODIMED (France).

Target Audience:

Vascular access device manufacturers and distributors

Interventional cardiology vascular device manufacturers

Research and consulting firms

Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)

Research institutes

Vendors/service providers

Niche companies manufacturing novel vascular access devices

Research and consulting firms

Scope of the Report:

The research report categorizes the global market into the following segments and subsegments:

By Type

Central Vascular Access Devices Peripherally inserted central catheters (PICC) Tunneled catheters Non tunneled catheters Implanted ports

Peripheral Vascular Access Devices Midline catheter (short) devices Midclavicular catheter (Midline) devices Winged steel needles

Accessories

By Application

Drug administration

Fluid and nutrition administration

Blood transfusion

Diagnostics & testing

By End User

Hospitals

Clinics and ambulatory care centers

Other end users

By Geography

North America U.S. Canada

Europe U.K. Germany France Rest of Europe (RoE)

Asia-Pacific

Rest of the World (RoW) Japan

RoW Latin America Middle East & Africa



Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Geographic Analysis

Further breakdown of the rest of Europe segment into France, Finland, Sweden, and Switzerland

Company Information

Detailed analysis and profiling of additional market players (Up to 5)

The global vascular access device market is expected to reach USD 5.45 Billion by 2022 from USD 3.87 Billion in 2017, at a CAGR of 7.1%. The major drivers for the market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients.

The report analyzes the market by type, application, end user, and region. The type segment includes central vascular access devices, peripheral vascular access devices, and accessories. The central vascular access devices segment is expected to account for the largest share of the vascular access devices market in 2017. The dominant share of the market is attributed to the fact that central vascular access devices are used in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.

Based on application, the market is broadly classified into drug administration, fluids and nutrition administration, blood transfusion, and diagnostics and testing. The drug administration segment is estimated to account for the largest share of the market in 2017, the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases.

The end user segment of the market includes hospitals, clinics and ambulatory care centers, and other end users. In 2017, the hospital segment is expected to dominate this market. The large share of this segment can be attributed to the fact that a majority of vascular procedures are performed in hospital settings.

The geographic segments in this report include North America, Europe, Asia-Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S.; an increase in the number of cancer cases; and an increase in research and clinical trials for vascular access devices.

The major players in this market include Major players include Becton Dickinson and Company (U.S.), Smiths Medical, Inc. (U.K.), and C.R.Bard, Inc. (U.S.). Other players include Teleflex Incorporated (U.S.) B.Braun Melsungen Ag (Germany), Angiodynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodi med (France).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst